loading
Precedente Chiudi:
$3.12
Aprire:
$3.11
Volume 24 ore:
1.22M
Relative Volume:
0.27
Capitalizzazione di mercato:
$810.02M
Reddito:
$194.75M
Utile/perdita netta:
$-51.26M
Rapporto P/E:
-10.91
EPS:
-0.28
Flusso di cassa netto:
$-23.38M
1 W Prestazione:
-2.40%
1M Prestazione:
-18.75%
6M Prestazione:
+69.72%
1 anno Prestazione:
+119.00%
Intervallo 1D:
Value
$3.05
$3.14
Intervallo di 1 settimana:
Value
$3.03
$3.22
Portata 52W:
Value
$1.24
$4.0787

Akebia Therapeutics Inc Stock (AKBA) Company Profile

Name
Nome
Akebia Therapeutics Inc
Name
Telefono
617-871-2098
Name
Indirizzo
245 FIRST STREET, CAMBRIDGE, MA
Name
Dipendente
181
Name
Cinguettio
@akebiatx
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
AKBA's Discussions on Twitter

Confronta AKBA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
AKBA
Akebia Therapeutics Inc
3.055 824.60M 194.75M -51.26M -23.38M -0.28
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
151.97 67.75B 9.39B 2.62B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.24 47.88B 29.96B 957.25M 4.77B 0.304
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.84 43.70B 14.26B 1.98B 2.47B 0.4347
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
18.55 21.51B 16.70B -157.13M 1.19B -0.155
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
377.11 18.31B 2.99B 1.21B 1.13B 25.06

Akebia Therapeutics Inc Stock (AKBA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-04 Ripresa H.C. Wainwright Buy
2025-04-28 Iniziato Leerink Partners Outperform
2025-04-01 Iniziato Jefferies Buy
2023-11-29 Ripresa BTIG Research Buy
2023-08-28 Aggiornamento H.C. Wainwright Neutral → Buy
2023-05-31 Aggiornamento Piper Sandler Neutral → Overweight
2022-03-31 Downgrade H.C. Wainwright Buy → Neutral
2022-03-31 Downgrade Mizuho Buy → Neutral
2022-03-31 Downgrade Needham Buy → Hold
2022-03-31 Downgrade Piper Sandler Overweight → Neutral
2021-03-08 Iniziato Cantor Fitzgerald Overweight
2021-01-29 Downgrade JP Morgan Neutral → Underweight
2019-11-14 Reiterato Needham Buy
2019-08-06 Reiterato H.C. Wainwright Buy
2019-07-11 Reiterato H.C. Wainwright Buy
2019-05-02 Iniziato JP Morgan Overweight
2019-03-20 Iniziato Citigroup Neutral
2018-09-07 Ripresa Morgan Stanley Equal-Weight
2018-08-10 Reiterato Needham Buy
2018-06-06 Reiterato H.C. Wainwright Buy
2017-12-19 Iniziato Piper Jaffray Overweight
2017-12-07 Iniziato BTIG Research Buy
2017-09-15 Iniziato RBC Capital Mkts Sector Perform
2017-07-10 Reiterato H.C. Wainwright Buy
2017-04-27 Reiterato H.C. Wainwright Buy
2017-04-27 Reiterato Needham Buy
2016-12-27 Reiterato H.C. Wainwright Buy
2016-12-20 Reiterato JMP Securities Mkt Outperform
2016-11-15 Iniziato Aegis Capital Buy
2016-09-29 Iniziato Brean Capital Buy
2016-03-16 Reiterato Needham Buy
2016-01-21 Iniziato Credit Suisse Neutral
Mostra tutto

Akebia Therapeutics Inc Borsa (AKBA) Ultime notizie

pulisher
Sep 03, 2025

Does Akebia Therapeutics Inc. have pricing powerWeekly Stock Analysis & Verified Swing Trading Watchlist - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Strategies to average down on Akebia Therapeutics Inc.2025 Market Outlook & Intraday High Probability Setup Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will Akebia Therapeutics Inc. outperform the marketJuly 2025 Setups & Step-by-Step Trade Execution Guides - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Using Python tools to backtest Akebia Therapeutics Inc. strategiesBond Market & Real-Time Stock Entry Alerts - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Regression analysis insights on Akebia Therapeutics Inc. performanceTrade Analysis Report & Long-Term Safe Investment Plans - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Understanding Akebia Therapeutics Inc.’s price movementRecession Risk & High Return Stock Watch Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Akebia Therapeutics reports inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener

Sep 02, 2025
pulisher
Sep 02, 2025

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Sep 02, 2025
pulisher
Sep 02, 2025

95,100 Shares at $3.14: Akebia Therapeutics Grants Inducement Stock Options to Key New Hires - Stock Titan

Sep 02, 2025
pulisher
Sep 02, 2025

Stock Report: Can Akebia Therapeutics Inc. stock outperform in a bear market2025 Earnings Surprises & Accurate Buy Signal Notifications - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Does Akebia Therapeutics Inc. have declining or rising EPSJuly 2025 Price Swings & Verified Momentum Stock Ideas - khodrobank.com

Sep 02, 2025
pulisher
Sep 01, 2025

Analyzing drawdowns of Akebia Therapeutics Inc. with statistical toolsJuly 2025 Short Interest & Fast Entry and Exit Trade Plans - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Measuring Akebia Therapeutics Inc.’s beta against major indicesTreasury Yields & Long-Term Growth Plans - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Can Akebia Therapeutics Inc. stock outperform in a bear marketMarket Growth Review & High Win Rate Trade Tips - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

What is Akebia Therapeutics Inc. s 5 year growth outlookEarnings Growth Report & Weekly Setup with ROI Potential - خودرو بانک

Sep 01, 2025
pulisher
Aug 31, 2025

Akebia Therapeutics Inc. Stock Recovery Path — Analyst Breakdown2025 Momentum Check & Stock Market Timing Techniques - beatles.ru

Aug 31, 2025
pulisher
Aug 31, 2025

Is Akebia Therapeutics Inc. reversing from oversold territoryJuly 2025 Trade Ideas & Fast Exit and Entry Strategy Plans - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Is Akebia Therapeutics Inc. forming a bottoming baseJuly 2025 Weekly Recap & Reliable Volume Spike Trade Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

How moving averages guide Akebia Therapeutics Inc. tradingMarket Trend Summary & Reliable Momentum Entry Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Visual trend scoring systems applied to Akebia Therapeutics Inc.Market Trend Review & Free Reliable Trade Execution Plans - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Using Bollinger Bands to evaluate Akebia Therapeutics Inc.2025 Technical Overview & Weekly High Return Stock Forecasts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Using Ichimoku Cloud for Akebia Therapeutics Inc. technicalsMarket Activity Report & Weekly Chart Analysis and Guides - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Why Akebia Therapeutics Inc. stock attracts strong analyst attentionJuly 2025 Breakouts & High Conviction Trade Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

What Fibonacci levels say about Akebia Therapeutics Inc. reboundJuly 2025 Sector Moves & Safe Swing Trade Setups - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

How to interpret RSI for Akebia Therapeutics Inc. stockEarnings Trend Report & Verified Entry Point Signals - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Elliott Wave Theory Predicts Pullback in Akebia Therapeutics Inc. getLinesFromResByArray error: size == 0 - 더경남뉴스

Aug 31, 2025
pulisher
Aug 30, 2025

Sentiment analysis tools applied to Akebia Therapeutics Inc.Market Growth Summary & AI Driven Stock Price Forecasts - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Earnings Chart Overlay Points to Akebia Therapeutics Inc. UpsideJuly 2025 Trade Ideas & Reliable Price Action Trade Plans - beatles.ru

Aug 30, 2025
pulisher
Aug 30, 2025

Biotech Movers: Akebia Shares Down After Pricing Stock Offering - TheStreet

Aug 30, 2025
pulisher
Aug 30, 2025

What’s the recovery path for long term holders of Akebia Therapeutics Inc.Volume Spike & Safe Capital Growth Tips - Newser

Aug 30, 2025
pulisher
Aug 29, 2025

Price momentum metrics for Akebia Therapeutics Inc. explainedPortfolio Gains Summary & Expert Curated Trade Setups - Newser

Aug 29, 2025

Akebia Therapeutics Inc Azioni (AKBA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$28.97
price down icon 3.37%
$17.23
price down icon 0.58%
drug_manufacturers_specialty_generic RDY
$14.15
price down icon 0.25%
$10.29
price down icon 2.32%
$138.05
price up icon 1.32%
$376.11
price down icon 3.78%
Capitalizzazione:     |  Volume (24 ore):